Wednesday, September 28, 2016

​Imprimis (IMMY) Sheds $3M in Expenses By Ceasing Operations at ...

https://www.equities.com/.../imprimis-immy-sheds-3m-in-expenses-by-ceasing-operati...
21 hours ago - Imprimis also provides compounded therapeutic alternatives; and non-proprietary customizable compounded drugs for humans and animals, including sterile .

No comments: